Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications

F Safri, R Nguyen, S Zerehpooshnesfchi… - Cancer Gene …, 2024 - nature.com
Hepatocellular Carcinoma (HCC) is one of the most common types of primary liver cancer.
Current treatment options have limited efficacy against this malignancy, primarily owing to …

Formation of a traditional Chinese medicine self-assembly nanostrategy and its application in cancer: a promising treatment

J Huang, Y Zhu, H **ao, J Liu, S Li, Q Zheng, J Tang… - Chinese Medicine, 2023 - Springer
Traditional Chinese medicine (TCM) has been used for centuries to prevent and treat a
variety of illnesses, and its popularity is increasing worldwide. However, the clinical …

MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function

Z Li, H Zhou, X Zhai, L Gao, M Yang, B An, T **a… - Cell Death & …, 2023 - nature.com
Cuproptosis caused by copper overload is mediated by a novel regulatory mechanism that
differs from previously documented mechanisms regulating cell death. Cells dependent on …

N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression

X Zhang, T Su, Y Wu, Y Cai, L Wang, C Liang, L Zhou… - Cancer Research, 2024 - AACR
Abstract N6-methyladenosine (m6A) RNA modification is the most common and conserved
epigenetic modification in mRNA and has been shown to play important roles in cancer …

Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular …

Y Wang, K Su, C Wang, T Deng, X Liu, S Sun… - Cell Death & …, 2024 - nature.com
Chemotherapeutic efficacy is seriously impeded by chemoresistance in more than half of
hepatocellular carcinoma (HCC) patients. However, the mechanisms involved in …

POSTN+ cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma

H Wang, Y Liang, Z Liu, R Zhang… - Journal for …, 2024 - pmc.ncbi.nlm.nih.gov
Objective Hepatocellular carcinoma (HCC) poses a significant clinical challenge because
the long-term benefits of immune checkpoint blockade therapy are limited. A comprehensive …

[HTML][HTML] CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent …

Y Lu, YT Chan, J Wu, Z Feng, H Yuan, Q Li… - Drug Resistance …, 2023 - Elsevier
Aims Therapeutic outcome of sorafenib in hepatocellular carcinoma (HCC) is undermined
by the development of drug resistance. This study aimed to identify the critical microRNA …

[HTML][HTML] Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the …

Q Deng, Y Huang, J Zeng, X Li, X Zheng, L Guo… - Biomedicine & …, 2024 - Elsevier
Background and aims Hepatocellular carcinoma (HCC) is one of the most common
malignancies in the world and the sixth leading cause of cancer death worldwide, and it is …

Ubiquitous protein lactylation in health and diseases

J Wang, Z Wang, Q Wang, X Li, Y Guo - Cellular & Molecular Biology …, 2024 - Springer
For decades, lactate has been considered a byproduct of glycolysis. The lactate shuttle
hypothesis shifted the lactate paradigm, demonstrating that lactate not only plays important …

[HTML][HTML] Natural Product Auraptene Targets SLC7A11 for Degradation and Induces Hepatocellular Carcinoma Ferroptosis

D Li, Y Li, L Chen, C Gao, B Dai, W Yu, H Yang, J Pi… - Antioxidants, 2024 - mdpi.com
The natural product auraptene can influence tumor cell proliferation and invasion, but its
effect on hepatocellular carcinoma (HCC) cells is unknown. Here, we report that auraptene …